Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-2,532,096
Put/Call ratio
34%
SEC-reported price per share
$47.97
Number of holders
580
Value change
-$62,290,479
Number of buys
320
Show 1 more signal
Number of sells
238
Security identity 1 source field
Shares outstanding
424,966,351

Security key

G7709Q104

Report period

Q1 2026

Institutions

580

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Legorreta G. Pablo
Disclosed value leader
Legorreta G. Pablo
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 20% 13D/G row: Legorreta G. Pablo Showing 1-6 of 15 holder rows.

Quick read

Legorreta G. Pablo leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
Legorreta G. Pablo 20%
MORGAN STANLEY 9.2%
Capital International Investors 8.8%
FMR LLC 6.5%
BlackRock, Inc. 5.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Legorreta G. Pablo
13D/G
20%
$3,372,819,557
103,112,796 shares
$0 16 May 2025
MORGAN STANLEY
13F 13D/G
Company
9.2%
from 13D/G
$2,135,790,095
55,274,069 shares
31 Dec 2025
Capital International Investors
13F 13D/G
Company
8.8%
from 13D/G
$1,201,870,500
31,104,309 shares
31 Dec 2025
FMR LLC
13F 13D/G
Company
6.5%
from 13D/G
$1,015,161,996
26,272,308 shares
31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
5.7%
from 13D/G
$1,011,931,068
26,188,692 shares
31 Dec 2025
Severgnini Achille G.
13D/G
5.7%
$978,612,513
24,223,082 shares
-$230,404,755 06 Nov 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
580
Shares
353,264,685
Rows available
580
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
537
Q1 2026 holders
580
Holder diff
43
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .